Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Yilmaz, Emre; Baran, Bülent; Soyer, Ozlem; Onel, Mustafa; Onel, Derya; Ormeci, Aslı; Gokturk, Suut; Evirgen, Sami; Akyuz, Filiz; Demir, Kadir; Besisik, Selman; Kaymakoglu, Sabahattin; Karaca, Cetin

doi:10.1016/j.cgh.2014.01.043

Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Atıf İçin Kopyala

Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., ...Daha Fazla

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 10
Basım Tarihi: 2014
Doi Numarası: 10.1016/j.cgh.2014.01.043
Dergi Adı: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1753-1758
Anahtar Kelimeler: Chronic Delta Hepatitis, SNP, Interferon Lambda 3, Immune Regulation, DELTA-HEPATITIS, HDV INFECTION, CIRRHOSIS, IL28B, ALPHA, TURKEY
İstanbul Üniversitesi Adresli: Evet

Özet

BACKGROUND & AIMS: We investigated the association between interferon lambda 3 (IFNL3) genotype (also known as interleukin 28B) and response to IFN alpha therapy in patients with chronic hepatitis D virus (HDV) infection.